Peripheral T/NK-cell lymphoma: A report of the IXth workshop of the European Association for Haematopathology

Histopathology

Volumn 38, Issue 3, 2001, Pages 250-270

  Kluin, P M ^a,h   Feller, A ^b   Gaulard, P ^c   Jaffe, E S ^d   Meijer, C J L M ^e   Muller Hermelink H K ^f   Pileri, S ^g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LÜBECK   (Germany)

^c HENRI MONDOR HOSPITAL   (France)

^d NATIONAL CANCER INSTITUTE   (United States)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Classification; Epstein Barr virus; NK cell; Non Hodgkin's lymphoma; Pathology; T cell

Indexed keywords

CD30 ANTIGEN; CELL PROTEIN; CYTOTOXIC FACTOR; GRANZYME B; PROTEIN EBER1; PROTEIN EBER2; PROTEIN TIA1; RECEPTOR SUBTYPE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CANCER CLASSIFICATION; CELL HETEROGENEITY; CELL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LEUKEMIA; LYMPHATIC LEUKEMIA; LYMPHOBLASTOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; NATURAL KILLER CELL; NATURAL KILLER CELL LEUKEMIA; NATURAL KILLER CELL LYMPHOMA; ORGAN TRANSPLANTATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROTEIN EXPRESSION; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; WORLD HEALTH ORGANIZATION;

EID: 0034832379     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01058.x     Document Type: Conference Paper

References (151)

1. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology
2. Non-Hodgkin's lymphomas in Asia
3. Peripheral T-cell lymphomas: An evaluation of reproducibility of the updated Kiel classification
4. Prognostic value of the histologic classification of peripheral T-cell lymphoma: A clinico-pathologic study of 71 HTLV-1 negative cases
5. Peripheral T-cell lymphoma: A clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification
6. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
7. Receptors on lymphocytes for endogenous splenic glycosaminoglycans
8. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study
9. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site
10. Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms
11. Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms
12. Primary non-Hodgkin's lymphoma of the intestine: High prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases
13. Recombinative events of the T cell antigen receptor δ gene in peripheral T cell lymphomas
14. + phenotypes are increased in coeliac disease
15. Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: Case report suggesting a possible histogenetic relationship
16. Abnormal intestinal intraepithelial lymphocytes in refractory sprue
17. Is adult-onset coeliac disease due to a low-grade lymphoma of intraepithelial T lymphocytes
18. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type
19. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma
20. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas
21. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas
22. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation
23. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules
24. Angio-immunoblastic lymphadenopathy with dysproteinaemia
25. Lymphogranulomatosis X. Klinisches bild, therapie und prognose
26. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease
27. Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course
28. Angioimmuno-blastic lymphadenopathy. Long-term follow-up study
29. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy
30. Angioimmunoblastic lymphadenopathy: Ten years' experience and state of current knowledge
31. Angioimmunoblastic lymphadenopathy-type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma
32. Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T- cell lymphoma by combined interphase and metaphase cytogenetics
33. Usefulness of follicular dendritic cell pattern in classification of peripheral T-cell lymphomas
34. Characteristic proliferations of reticular and dendritic cells in angioimmuno-blastic lymphoma
35. CNA.42, a new monoclonal antibody directed against a fixative- resistant antigen of follicular dendritic reticulum cells
36. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma
37. Polyclonal rearrangements of the T-cell receptor β-chain in fatal angioimmuno-blastic lymphadenopathy
38. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy
39. Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma
40. Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders
41. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers
42. Peripheral T-cell lymphoma with distinct perifollicular growth pattern: A distinct subtype of T-cell lymphoma?
43. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma
44. B-cell lymphoma after angioimmunoblastic lymphadenopathy: A case with oligoclonal gene rearrangements associated with Epstein-Barr virus
45. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
46. Updated Kiel classification for lymphomas
47. EORTC classification for primary cutaneous lymphomas: A proposal from the cutaneous lymphoma study group of the European Organization for Research and Treament of Cancer
48. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin: A clinico-pathologic and immunohistochemical study in 20 patients
49. Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis: A European multicenter study of 47 patients
50. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype
51. Ki-1-anaplastic large cell lymphoma: Is it a discrete entity?
52. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types
53. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes)
54. + T-cell lymphoma
55. Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma
56. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma
57. CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance
58. Anaplastic large cell lymphoma and its morphological variants
59. World Health Organization Classification of Neoplastic Disease of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting - Arlie House, Virginia, November 1997
60. Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients
61. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
62. ALK-positive lymphoma: A single disease with a broad spectrum of morphology
63. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype
64. Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma
65. A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas
66. CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35
67. Fusion of a kinase gene, ALK, to a nucleolar protein gene. NPM, in non-Hodgkin's lymphoma
68. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma
69. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2:5)
70. Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: Identification of the YY1 binding site at the 5′ enhancer region
71. ALK, the chromosome 2 gene locus altered by the t(2:5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
72. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
73. Diagnosis of t(2:5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry
74. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK. A distinct clinicopathologic entity
75. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood
76. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
77. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type
78. ALK expression defines a distinct group of T/null lymphomas ('ALK lymphomas') with a wide morphological spectrum
79. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the t(2:5) translocation
80. Anaplastic large cell lymphoma: A distinct molecular pathologic entity: A reappraisal with special reference to p80 (NPM/ALK) expression
81. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
82. Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma
83. Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study
84. Aggressive cutaneous NK and NK-like T-cell lymphomas: Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases
85. Aggressive natural killer cell leukaemia/lymphoma: Report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells
86. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
87. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association
88. Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia
89. Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation
90. Clonal diseases of large granular lymphocytes
91. Felty's and pseudo-Felty's syndromes
92. Large granular lymphocyte expansions in patients with Felty's syndrome: Analysis using anti-T-cell receptor V beta-specific monoclonal antibodies
93. Comparison of T cell receptor gene rearrangements in patients with large granular T cell leukemia and Felty's syndrome
94. - lymphoproliferative disease of granular lymphocytes
95. Clonal proliferation of large granular lymphocytes in rheumatoid arthritis
96. Lymphocytosis of large granular lymphocytes associated with anemia and neutropenia: Proof of monoclonality of the LGL-population, but benign clinical course
97. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: A T-cell clonopathy of undetermined significance
98. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia
99. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia
100. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes
101. T-cell lymphoma involving subcutaneous tissue: A clinicopathologic entity commonly associated with hemophagocytic syndrome
102. Histiocytic cytophagic panniculitis
103. Extranodal peripheral T-cell and NK-cell neoplasms
104. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
105. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage
106. CD5- CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
107. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China
108. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation
109. Granzyme B-expressing peripheral T-cell lymphomas: Neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization
110. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan
111. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas
112. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
113. CD56 (NKH1) -positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity
114. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma
115. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases
116. Expression of natural killer cell markers in non-Hodgkin's lymphomas
117. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections
118. Frequent expression of CD3 epsilon in CD3 (Leu 4)-negative nasal T-cell lymphomas
119. Non-hepatosplenic gamma delta T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin localization
120. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas
121. Hepatosplenic T-cell lymphoma: Sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta
122. Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen
123. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type
124. Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: A new cytogenetic-clinicopathologic entity
125. Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma
126. Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin
127. Gamma/delta T-cell hepatosplenic lymphoma: Review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia
128. Hepatosplenic gamma/delta T-cell lymphoma: A report of two cases in immunocompromised patients, associated with isochromosome 7q
129. T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: A case report
130. Isochromosome 7q: The primary cytogenetic abnormality in hepatosplenic gamma-delta T cell lymphoma
131. Malignant histiocytosis of the intestine: A T-cell lymphoma
132. T-cell intestinal lymphoma associated with celiac sprue
133. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes
134. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma
135. Enteropathy-associated T-cell lymphoma in the West of Ireland: Low-frequency of Epstein-Barr virus in these tumors
136. Expression of cytotoxic molecules in intestinal T-cell lymphomas
137. Enteropathy associated T cell lymphoma
138. Gastrointestinal malignancies in patients with celiac sprue
139. Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype
140. Oral T-cell lymphoma associated with celiac sprue. A case report
141. Long term survival after treatment of disseminated T cell lymphoma presenting with tracheal obstruction in a patient with coeliac disease
142. Malignant lymphoma in coeliac disease: Various manifestations with distinct symptomatology and prognosis?
143. Histopathology of the complications of celiac disease: Enteropathy-associated T cell lymphoma and ulcerative jejunitis
144. Are complicated forms of celiac disease cryptic T-cell lymphomas?
145. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population
146. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma
147. Eosinophilie als fuhrendes symptom eines hochmalignen enteropathie-assoziierten t- zell-lymphoms
148. Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL)
149. Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with gluten-sensitive enteropathy, pathological features, and immunophenotype
150. Most CD56+ intestinal lymphomas are CD8+ CD5- T-cell lymphomas of monomorphic small to medium size histology
151. Intestinal T-cell lymphoma: A reassessment of cytomorphological and phenotypic features in relation to patterns of small bowel remodelling